Support for researchers

Our wide range of research grants offers support to scientists at every stage of their careers, attracting the brightest and best into the fight against cystic fibrosis (CF).

Apply for funding

Are you a researcher with an interest in cystic fibrosis? We have a variety of research funding available, including:

• Our Strategic Research Centres, virtual centres of research excellence that are intended to create multidisciplinary teams to address questions of strategic relevance to people with cystic fibrosis
• Our Venture and Innovation Awards, which support transformational and innovative research projects by providing financial support and bringing funding into the field of CF from external sources
• Our Summer Studentships, which provide medical and basic science undergraduates with hands-on experience of research during the academic summer vacation

Apply for funding

Research noticeboard

Full of useful reminders of grant deadlines, conferences and workshops, this is your go-to page for important information to progress your research. Visit the Research noticeboard.

CF AMR Syndicate

The CF AMR Syndicate  brings industry leaders and people with CF together with academics with expertise in CF and lung infections, it is enabled and facilitated by the Trust and Medicines Discovery Catapult (MDC). For more information about the CF AMR Syndicate  and how to support its ongoing work, please visit the CF AMR Syndicate page on MDC’s website.

Researchfish

We use the online database Researchfish to evaluate the outcomes of the research we’re funding. Find out how Researchfish allows us to share the impact of our research with the CF community and generate income, and how you can submit your data.

Research innovation workshops

Research innovation workshops are a useful way of creating an environment, for experts outside of CF and established CF researchers, to explore ways of working together to crack a major problem. Previously we’ve run workshops on cancer and CF, understanding gut-related complications of CF and on clinical trials respectively.